The FDA has approved Awiqli, the first once‑weekly long‑acting basal insulin, for adults with type 2 diabetes, which offers ...

Add Yahoo as a preferred source to see more of our stories on Google. Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical trials ...

The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults ...

Novo Nordisk’s icodec-abae is now approved in the US for type 2 diabetes only, after a prior rejection partly due to concerns about hypoglycemia in type 1 diabetes.

Some patients with type 2 diabetes will be able to switch from daily insulin injections to this first-of-its-kind once-weekly ...

Sept 11 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present the latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free ...

The Food and Drug Administration said several lots of six products containing benzoyl peroxide are being recalled. - Sarah Silbiger/Getty Images Most types of insulin therapy, an important part of ...

A new LOCAL online community built for you. Click now to see all the available groups. WEDNESDAY, Sept. 11, 2024 (HealthDay News) -- Weekly insulin shots can help control both type 1 and type 2 ...

Life with diabetes usually includes many injections of the blood sugar–controlling hormone insulin. Recent research investigating a once-weekly shot finds it might help lessen the burden a bit for ...

Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical trials have found. A new class of insulin called efsitora alfa has been ...

The FDA approved a once-weekly, long-acting basal insulin for adults with type 2 diabetes as an alternative to daily basal ...